Keiko Kasutani

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

Masahiko Mihara, Keiko Kasutani, Makoto Okazaki et al. · International Immunopharmacology · 2005 · 318 citations

Inflammation, Il-6 Cytokine Family, Cytokine +14

Anti‐<scp>IL</scp>‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice

Keiko Kasutani, Etsuko Fujii, Satoko Ohyama et al. · British Journal of Pharmacology · 2014 · 73 citations · Full text

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 54 citations · Full text

Requirement for Cooperative Interaction of Interleukin-6 Responsive Element Type 2 and Glucocorticoid Responsive Element in the Synergistic Activation of Mouse Metallothionein-I Gene by Interleukin-6 and Glucocorticoid

Keiko Kasutani, Norio Itoh, Masako Kanekiyo et al. · Toxicology and Applied Pharmacology · 1998 · 34 citations

Inflammation, Cytokine, Autoimmune Disease +10

Blocking effect of anti-mouse interleukin-6 monoclonal antibody and glucocorticoid receptor antagonist, RU38486, on metallothionein-inducing activity of serum from lipopolysaccharide-treated mice

Norio Itoh, Keiko Kasutani, Norio Muto et al. · Toxicology · 1996 · 27 citations

Inflammation, Cytokine, Anti-inflammatory +11